Beatriz Barquiel Alcalá | Qualitative Research | Best Research Article Award

Published on by Research Data Analysis

Dr. Beatriz Barquiel Alcalá | Qualitative Research | Best Research Article Award

Hospital Universitario La Paz | Spain

Dr. Beatriz Barquiel Alcalá is a physician-scientist specializing in endocrinology and nutrition, with a clinical appointment since 2010 at Hospital Universitario La Paz in Madrid. She holds a Licentiate in Medicine and Surgery from the University of Granada (2005) and completed further training under RD 99/2011 at the Universidad Autónoma de Madrid in 2012. Over her career she has published widely on diabetes and pregnancy, gestational and pregestational diabetes, maternal weight gain, and metabolic outcomes, including contributions as corresponding author. Her work spans over 30 scientific articles (e.g. on glycemic control, gestational weight gain, twin versus singleton pregnancies, neonatal outcomes, continuous glucose monitoring) as well as book chapters on hypertensive disorders, exercise in gestational diabetes, and obesity in pregnancy. She has led or participated in multiple funded projects—among them randomized trials and studies on biomarker validation, dietary interventions in pregnancy, and predictors of glycemic control. She also undertook a research stay at Memorial Sloan Kettering (USA) in 2009–2010. Her research interests lie at the intersection of maternal–fetal medicine, diabetes, metabolic programming, and endocrinology innovations.

Profile : Scopus

Featured Publications

Aguilera-García, I., Barquiel-Alcalá, B., Vázquez-Pérez, P., Prados-Sánchez, M.C., & González-Pérez de Villar, N. (2025). Time to change guidelines? Suboptimal glycemic control measures by CGM associated with cystic fibrosis exacerbations despite adequate HbA1c. Acta Diabetológica.

Borrego Soriano, I., Barquiel-Alcalá, B., Moreno-Domínguez, O., Qasem Moreno, A.L., García-Pérez de Sevilla, E., & González-Pérez de Villar, N. (2025). Screening system for the detection of unknown or poorly controlled diabetes mellitus in a tertiary hospital: A retrospective study. Journal of Evaluation in Clinical Practice.

Quirós, C., Herrera, M.T., Amigó, J., Perea, V., Barquiel, B., et al. (2024). Real-world evidence of off-label use of commercially automated insulin delivery systems compared to multiple daily insulin injections in pregnancies complicated by type 1 diabetes. Diabetes Technology & Therapeutics.

Barquiel, B. (AC), Calvo, M., Moreno-Domínguez, O., Bartha, J.L., et al. (2023). The PREDG study: A randomised controlled trial testing whether an educational intervention can prevent gestational weight gain in women with obesity. Clinical Nutrition ESPEN.

García-Moreno, C., Benítez-Valderrama, P., Barquiel, B., González-Pérez de Villar, N., Hillman, N., Lora Pablos, A., & Herranz, L. (2022). Efficacy of continuous glucose monitoring on maternal and neonatal outcomes in gestational diabetes mellitus: A systematic review and meta-analysis of randomized clinical trials. Diabetic Medicine.

 

Alexia Iasonos | Algorithm Development | Best Researcher Award

Published on by Research Data Analysis

Dr. Alexia Iasonos | Algorithm Development | Best Researcher Award

Memorial Sloan-Kettering Cancer Center | United States

Dr. Alexia E. Iasonos is a recognized expert in biostatistics, currently a Member at Memorial Sloan Kettering Cancer Center where she serves as Director of Clinical Research Development. She earned her B.S. in Mathematics & Statistics from the University of Cyprus (1992-96), followed by an M.S. in Biometry & Statistics and a Ph.D. in Biometry & Statistics from SUNY Albany (awarded in 1998 and 2002 respectively). Her professional trajectory includes roles in academic statistics, pharmaceutical industry, and extensive hospital-affiliated clinical trial biostatistics. Her methodological research focuses on design and analysis of clinical trials, especially Bayesian adaptive Phase I and II designs, dose-finding methods, dose-expansion cohort development, predictive modeling and nomograms, biomarker evaluation and endpoints, particularly in gynecologic oncology. Her work has been instrumental in improving early drug development processes. According to AD Scientific Index, her h-index is 52, with over 10,779 total citations. She is an elected Fellow of the Society of Clinical Trials, deputy editor of Journal of Clinical Oncology, member/chair in several protocol and monitoring committees. Among her awards are those tied to leadership in early-phase trial methodology and contributions to cancer biostatistics. In conclusion, Dr. Iasonos continues to make high impact contributions in biostatistics and oncology by combining rigorous methodology with translational collaboration.

Profile : Scopus

Featured Publications

Iasonos, A. (2024). Evaluation of early phase dose finding algorithms in heterogeneous populations. Journal of Statistical Planning and Inference.

Iasonos, A. (2023). Controlled amplification in oncology dose-finding trials. Contemporary Clinical Trials.

Iasonos, A. (2022). Stopping rules for phase I clinical trials with dose expansion cohorts. Statistical Methods in Medical Research.

Iasonos, A. (2021). Controlled backfill in oncology dose-finding trials. Contemporary Clinical Trials.

Iasonos, A. (2021). Phase I clinical trials in adoptive T-cell therapies. Journal of the Royal Statistical Society: Series C (Applied Statistics).

Dong Ha Lee – New advance technology in osteoporosis diagnosis – Young Scientist Award 

Published on by Research Data Analysis

Assist Prof Dr. Dong Ha Lee - New advance technology in osteoporosis diagnosis - Young Scientist Award 

Busan Medical Center - South Korea

Author Profile

Early Academic Pursuits

Assist Prof Dr. Dong Ha Lee's journey in the medical field began with a solid foundation in academia. Graduating with a Doctor of Medicine (M.D.) degree from Pusan National University in Busan, South Korea, Lee exhibited a keen interest in orthopedic surgery from an early stage. His pre-medical education laid the groundwork for his future professional endeavors, emphasizing the importance of a comprehensive understanding of medical science and patient care.

Professional Endeavors

Assist Prof Dr. Lee's professional career as an orthopedic surgeon commenced at Busan Medical Center in 2019. Since then, he has demonstrated exceptional skills and dedication to his craft. As an orthopedic surgeon, Lee has been instrumental in diagnosing and treating a wide range of musculoskeletal conditions, with a particular focus on osteoporosis and osteoporotic fractures. His expertise extends to spine correction deformity and tumor surgeries, showcasing his versatility in addressing complex orthopedic issues.

Throughout his tenure, Lee has conducted thorough physical examinations, evaluated patient histories, and performed pre-operative and post-operative assessments with precision. His involvement in surgical procedures, including arthroscopic surgeries and joint replacements, underscores his proficiency in utilizing advanced techniques to optimize patient outcomes.

Contributions and Research Focus On New advance technology in osteoporosis diagnosis

Beyond his clinical responsibilities, Lee has actively contributed to the advancement of orthopedic knowledge through research and education. With over 10 published research papers as a corresponding author, Lee has made significant contributions to the scientific community, particularly in the realm of musculoskeletal health. His research endeavors have encompassed topics ranging from the management of osteoporosis to innovative surgical techniques for joint reconstruction.

Additionally, Lee has played a pivotal role in training and mentoring medical students, trainees, and residents, imparting his expertise and fostering competency within the field. His dedication to education underscores his commitment to shaping the next generation of orthopedic professionals.

Accolades and Recognition

Assist Prof Dr. Lee's exemplary contributions to the field of orthopedic surgery have garnered widespread recognition and accolades. Notably, his participation in research studies and presentations has earned him prestigious awards, including the ICO 2021 best oral presentation award. As a chief resident, Lee has been acknowledged for his leadership and outstanding contributions to patient care and academic excellence.

Furthermore, Lee's commitment to advancing orthopedic knowledge is evidenced by his involvement in esteemed organizations such as the FIFA Medical Network and his certification as an ACLS provider. His multifaceted achievements reflect a relentless pursuit of excellence in both clinical practice and academic pursuits.

Impact and Influence

Assist Prof Dr. Lee's impact extends beyond the confines of his clinical practice, leaving a lasting impression on colleagues, patients, and the broader medical community. Through his innovative research, compassionate patient care, and dedication to education, Lee has contributed to the advancement of orthopedic surgery while positively influencing the lives of countless individuals.

Legacy and Future Contributions

As Lee continues to make strides in the field of orthopedic surgery, his legacy as a skilled clinician, educator, and researcher will endure. With a steadfast commitment to excellence and a passion for improving patient outcomes, Lee's future contributions are poised to further elevate the standards of orthopedic care and leave a lasting impact on the field for years to come.

Notable Publication